MENU
IMNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunome (IMNM) Ownership - Who owns Immunome?

Immunome Inc is a biopharmaceutical company... Show more

Profile

Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
863.49M
P/E Ratio
N/A
Total Cash
268.04M
Projected Growth
N/A
Total Debt
4.14M
Revenue
12.59M
Risk (Beta)
2.98
Dividend Yield
N/A
Total Cash/Share
3.08
Total Debt/Equity
N/A
Revenue/Share
0.17 USD as % of share price

Fundamentals

IMNM
Capitalization
863M
P/E Ratio
N/A
Risk (Beta)
2.98
Dividend Yield
N/A
Total Cash
268M
Total Cash/Share
3.08
Total Debt
4.14M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.17%
Revenue
12.6M
ROE
N/A
Book Value
269M
P/B Ratio
3.21
Cash Flow
N/A
Earnings
-3.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
12.13
Current Revenue Per Employee
25903.23
Dividends Per Share - Security
N/A
EBITDA
-187.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-71.69
Shares Held By Institutions
904M
Shares Outstanding - Current
87M
Total Liabilities
27M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-6.591
View a ticker or compare two or three
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMNM showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18702 N. Creek Parkway
Phone
+1 610 321-3700
Employees
55
Web
https://www.immunome.com